These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34116817)

  • 1. Increasing access to family planning services among women receiving medications for opioid use disorder: A pilot randomized trial examining a peer-led navigation intervention.
    Rinehart DJ; Stowell M; Collings A; Durfee MJ; Thomas-Gale T; Jones HE; Binswanger I
    J Subst Abuse Treat; 2021 Jul; 126():108318. PubMed ID: 34116817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives among women receiving medications for opioid use disorder: Implications for development of a peer navigation intervention to improve access to family planning services.
    Stowell MA; Thomas-Gale T; Jones HE; Binswanger I; Rinehart DJ
    Subst Abus; 2022; 43(1):722-732. PubMed ID: 35100081
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex and female empowerment (SAFE): A randomized trial comparing sexual health interventions for women in treatment for opioid use disorder.
    Jones HE; Martin CE; Andringa KR; Ellerson RM; Johnson E; Hairston E; O' Grady KE
    Drug Alcohol Depend; 2021 Apr; 221():108634. PubMed ID: 33676071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study.
    Day CA; White B; Reid SE; Fowler M; Black KI
    Aust N Z J Public Health; 2020 Oct; 44(5):360-362. PubMed ID: 32865845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient navigation for pregnant individuals with opioid use disorder: Results of a randomized multi-site pilot trial.
    Cochran G; Smid MC; Krans EE; Yu Z; Carlston K; White A; Abdulla W; Baylis J; Charron E; Okifugi A; Gordon AJ; Lundahl B; Silipigni J; Seliski N; Haaland B; Tarter R
    Addiction; 2024 Mar; 119(3):544-556. PubMed ID: 37859587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Cost-Benefit of Onsite Contraceptive Services With and Without Incentives Among Women With Opioid Use Disorder at High Risk for Unintended Pregnancy: A Randomized Clinical Trial.
    Heil SH; Melbostad HS; Matusiewicz AK; Rey CN; Badger GJ; Shepard DS; Sigmon SC; MacAfee LK; Higgins ST
    JAMA Psychiatry; 2021 Oct; 78(10):1071-1078. PubMed ID: 34259798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Averting neonatal abstinence syndrome and treating addiction among rural, opioid-using young women.
    Cooper RL; Crosby RA; Martin PR; Edgerton R
    Am J Addict; 2022 Sep; 31(5):441-446. PubMed ID: 35535402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
    Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
    Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.
    Stancil SL; Miller MK; Duello A; Finocchario-Kessler S; Goggin K; Winograd RP; Hurley EA
    Harm Reduct J; 2021 Aug; 18(1):83. PubMed ID: 34348734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
    Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
    Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Video directly observed therapy intervention using a mobile health application among opioid use disorder patients receiving office-based buprenorphine treatment: protocol for a pilot randomized controlled trial.
    Schramm ZA; Leroux BG; Radick AC; Ventura AS; Klein JW; Samet JH; Saxon AJ; Kim TW; Tsui JI
    Addict Sci Clin Pract; 2020 Jul; 15(1):30. PubMed ID: 32736660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder.
    Evans EA; Yoo C; Huang D; Saxon AJ; Hser YI
    J Subst Abuse Treat; 2019 Nov; 106():19-28. PubMed ID: 31540607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It takes a village: A pilot study of a group telehealth intervention for support persons affected by opioid use disorder.
    Osilla KC; Manuel JK; Becker K; Nameth K; Burgette L; Ober AJ; DeYoreo M; Lodge BS; Hurley B; Watkins KE
    J Subst Use Addict Treat; 2024 Jun; 161():209290. PubMed ID: 38272117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does co-location of medication assisted treatment and prenatal care for women with opioid use disorder increase pregnancy planning, length of interpregnancy interval, and postpartum contraceptive uptake?
    Collier KW; MacAfee LK; Kenny BM; Meyer MC
    J Subst Abuse Treat; 2019 Mar; 98():73-77. PubMed ID: 30665607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
    Schiff DM; Nielsen T; Hoeppner BB; Terplan M; Hansen H; Bernson D; Diop H; Bharel M; Krans EE; Selk S; Kelly JF; Wilens TE; Taveras EM
    JAMA Netw Open; 2020 May; 3(5):e205734. PubMed ID: 32453384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
    Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.